Synthetic modification of salinomycin: selective O-acylation and biological evaluation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic modification of salinomycin: selective O-acylation and biological evaluation
Authors
Keywords
-
Journal
CHEMICAL COMMUNICATIONS
Volume 49, Issue 85, Pages 9944
Publisher
Royal Society of Chemistry (RSC)
Online
2013-09-03
DOI
10.1039/c3cc45983g
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis and antimicrobial activity of amide derivatives of polyether antibiotic—salinomycin
- (2012) Adam Huczyński et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Polyether ionophores—promising bioactive molecules for cancer therapy
- (2012) Adam Huczyński BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antiproliferative activity of salinomycin and its derivatives
- (2012) Adam Huczyński et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress
- (2012) K Ketola et al. BRITISH JOURNAL OF CANCER
- Salinomycin as a Drug for Targeting Human Cancer Stem Cells
- (2012) Cord Naujokat et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- X-ray, FT-IR, NMR and PM5 structural studies and antibacterial activity of unexpectedly stable salinomycin–benzotriazole intermediate ester
- (2012) Adam Huczyński et al. JOURNAL OF MOLECULAR STRUCTURE
- Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species
- (2012) Berlinda Verdoodt et al. PLoS One
- Cancer stem cells and metastasis
- (2012) Katia Sampieri et al. SEMINARS IN CANCER BIOLOGY
- Zinc complex mediated regioselective O-acylation of therapeutic agents
- (2012) Rong Tong et al. Chemical Science
- Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization
- (2011) Kwang-Youn Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Salinomycin - A New Cancer Drug Candidate
- (2011) Adam Huczynski Chemical Biology & Drug Design
- Regioselective enzymatic acylation of complex natural products: expanding molecular diversity
- (2011) Javier González-Sabín et al. CHEMICAL SOCIETY REVIEWS
- Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells
- (2011) Desheng Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor
- (2010) Roberta Riccioni et al. BLOOD CELLS MOLECULES AND DISEASES
- Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein
- (2010) Ju-Hwa Kim et al. BRITISH JOURNAL OF PHARMACOLOGY
- The therapeutic promise of the cancer stem cell concept
- (2010) Natasha Y. Frank et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
- (2009) Piyush B. Gupta et al. CELL
- N,N,N′,N′-Tetramethylchloroformamidinium Hexafluorophosphate (TCFH), a Powerful Coupling Reagent for Bioconjugation
- (2008) Judit Tulla-Puche et al. BIOCONJUGATE CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now